These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [New knowledge on the pathogenesis of chronic inflammatory bowel diseases: what have we learned from colitis animal models?]. Seibold F; Egger B; Göke B Schweiz Med Wochenschr; 2000 May; 130(20):749-55. PubMed ID: 10920852 [TBL] [Abstract][Full Text] [Related]
4. Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease. Powrie F; Uhlig H Novartis Found Symp; 2004; 263():164-74; discussion 174-8, 211-8. PubMed ID: 15669641 [TBL] [Abstract][Full Text] [Related]
5. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease. Uhlig HH; Powrie F Eur J Immunol; 2009 Aug; 39(8):2021-6. PubMed ID: 19672896 [TBL] [Abstract][Full Text] [Related]
7. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Dieleman LA; Peña AS; Meuwissen SG; van Rees EP Scand J Gastroenterol Suppl; 1997; 223():99-104. PubMed ID: 9200314 [TBL] [Abstract][Full Text] [Related]
8. Role of microecology in chronic inflammatory bowel diseases. Guarner F; Casellas F; Borruel N; Antolín M; Videla S; Vilaseca J; Malagelada JR Eur J Clin Nutr; 2002 Dec; 56 Suppl 4():S34-8. PubMed ID: 12556945 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease: a model of chronic inflammation-induced cancer. Yang GY; Taboada S; Liao J Methods Mol Biol; 2009; 511():193-233. PubMed ID: 19347299 [TBL] [Abstract][Full Text] [Related]
10. Gene transfer approaches for the treatment of inflammatory bowel disease. Wirtz S; Neurath MF Gene Ther; 2003 May; 10(10):854-60. PubMed ID: 12732871 [TBL] [Abstract][Full Text] [Related]
11. [Animal experiment models of chronic inflammatory bowel diseases]. Reinshagen M; Eysselein VE Z Gastroenterol; 1993 May; 31(5):315-21. PubMed ID: 8322478 [TBL] [Abstract][Full Text] [Related]
13. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management]. Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439 [TBL] [Abstract][Full Text] [Related]
14. Animal models of inflammatory bowel disease: lessons from enteric infections. Eckmann L Ann N Y Acad Sci; 2006 Aug; 1072():28-38. PubMed ID: 17057188 [TBL] [Abstract][Full Text] [Related]
15. The genetic background of inflammatory bowel disease. Yang H; Rotter JI Hepatogastroenterology; 2000; 47(31):5-14. PubMed ID: 10690581 [TBL] [Abstract][Full Text] [Related]
16. Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours. Wedemeyer J; Vosskuhl K Best Pract Res Clin Gastroenterol; 2008; 22(3):537-49. PubMed ID: 18492570 [TBL] [Abstract][Full Text] [Related]
17. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. Jagtap AG; Shirke SS; Phadke AS J Ethnopharmacol; 2004 Feb; 90(2-3):195-204. PubMed ID: 15013181 [TBL] [Abstract][Full Text] [Related]
18. [Biologic therapy of inflammatory bowel disease]. Baumgart DC; Wiedenmann B; Dignass AU Z Gastroenterol; 2003 Oct; 41(10):1017-32. PubMed ID: 14562200 [TBL] [Abstract][Full Text] [Related]
19. Etiology and pathophysiology of inflammatory bowel disease--environmental factors. Andus T; Gross V Hepatogastroenterology; 2000; 47(31):29-43. PubMed ID: 10690583 [TBL] [Abstract][Full Text] [Related]
20. Development and validation of a novel IL-10 deficient cell transfer model for colitis. Ikenoue Y; Tagami T; Murata M Int Immunopharmacol; 2005 Jun; 5(6):993-1006. PubMed ID: 15829415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]